REFERENCES
- Stam R W, Boer M L, Pieters R. Towards targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol 2006; 132: 539–551
- Leiper A D, Chessells J. Acute lymphoblastic leukaemia under 2 years. Arch Dis Child 1986; 61: 1007–1012
- Stam R W, den Boer M L, Passier M M, et al. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Leukemia 2006; 20: 264–271
- Pui C H, Ribeiro R C, Campana D, et al. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952–956
- Crist W, Pullen J, Boyett J, et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Blood 1986; 67: 135–140
- Stark B, Vogel R, Cohen I J, et al. Biologic and cytogenetic characteristics of leukemia in infants. Cancer 1989; 63: 117–125
- Kosaka Y, Koh K, Kinukawa N, et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 2004; 104: 3527–3534
- Pui C H, Gaynon P S, Boyett J M, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915
- De Braekeleer M, Morel F, Le Bris M J, et al. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res 2005; 25: 1931–1944
- Pui C H, Frankel L S, Carroll A J, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 1991; 77: 440–447
- Pui C H, Chessells J M, Camitta B, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17: 700–706
- Pui C H, Crist W M, Look A T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449–1463
- Eguchi-Ishimae M, Eguchi M, Ishii E, et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005; 90: 1511–1515
- Smith M T, Wang Y, Skibola C F, et al. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002; 100: 4590–4593
- Wiemels J L, Pagnamenta A, Taylor G M, et al. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 1999; 59: 4095–4099